Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. Immunofluorescence: 1/200 - 1/1000. ELISA: 1/20000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human PPP1R14C. AA range:51-100
Subcellular Location
Cytoplasm . Membrane
Peripheral membrane protein .
Peripheral membrane protein .
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
81706
Observed Band
20kD
Other Name
KEPI
Kinase-enhanced PP1 inhibitor
PKC-potentiated PP1 inhibitory protein
PPP1R14C
Protein phosphatase 1 regulatory subunit 14C
Serologically defined breast cancer antigen NY-BR-81
Kinase-enhanced PP1 inhibitor
PKC-potentiated PP1 inhibitory protein
PPP1R14C
Protein phosphatase 1 regulatory subunit 14C
Serologically defined breast cancer antigen NY-BR-81
Background
The degree of protein phosphorylation is regulated by a balance of protein kinase and phosphatase activities. Protein phosphatase-1 (PP1
see MIM 176875) is a signal-transducing phosphatase that influences neuronal activity, protein synthesis, metabolism, muscle contraction, and cell division. PPP1R14C is an inhibitor of PP1 (Liu et al., 2002 [PubMed 11812771]).[supplied by OMIM, Feb 2010],
see MIM 176875) is a signal-transducing phosphatase that influences neuronal activity, protein synthesis, metabolism, muscle contraction, and cell division. PPP1R14C is an inhibitor of PP1 (Liu et al., 2002 [PubMed 11812771]).[supplied by OMIM, Feb 2010],